Phastar
Steve Kent is a seasoned executive with extensive experience in leadership roles across various organizations in the biopharmaceutical sector. Currently serving as Chairperson at PHASTAR and Chairman at CSL Group, Steve has previously held significant positions including Non-Executive Chairman at firms such as 4ways, Pharmaspectra, Phlexglobal, and CRF Health. Notably, Steve was instrumental in the strategic buyouts of both CRF Health and Phlexglobal during their tenure. Prior to these roles, Steve served as President of Perceptive Informatics after PAREXEL's acquisition of ClinPhone, where Steve was Managing Director. Educationally, Steve holds a degree from the University of East Anglia, specializing in Business/Commerce.
This person is not in the org chart
This person is not in any teams
Phastar
Phastar is a specialist biometrics contract research organization offering statistical consulting, clinical trial reporting, data management and data science services by providing expert consultants and managing and delivering in-house projects, FSP-style arrangements and preferred partnerships. Our number one priority is ensuring on time, quality work: every project undertaken is supervised on methodology and utilizes internal processes designed to guarantee optimal quality, inspired by 4,000 years accumulated technical experience across the company. Phastar is headquartered in London (UK) and North Carolina (US) and has 15 offices worldwide